Among the drug classes under investigation for AD are the glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are approved for the treatment of type 2 diabetes (T2D), obesity and cardiovascular disease
Conclusion In this large real-world study emulating a target trial, initiation of GLP-1 RA therapy among patients with T2DM was associated with a modestly higher incidence of psoriasis and lower incidences of pemphigus and bullous pemphigoid compared with DPP-4i therapy, while no increased risk was observed for most other autoimmune or inflammatory skin diseases
The GLP-1 space is really heating up
Mass spectrometry (MS) confirmation of the correct molecular weight (1,419.53 Da) is the complementary identity test
Recent studies have revealed that YAP1 can influence cellular sensitivity to ferroptosis by regulating ferroptosis-related genes such as SLC7A11 and GPX4 (Wang et al., 2023c)
Therefore, a collagen product that includes Vitamin C actively supports skin repair and structural integrity beyond basic offerings
